D002981Chemicals & DrugsD03.383.773.532.500.125D09.408.471.500.125330.99715Clindamycincmhprofilesont:personsuffixperson suffixprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation Resourcevivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonMDSusanaChavez-BuenoSusana Chavez-Bueno0.000000000000000.00000000000000103Chavez-Bueno, Susana0000-0001-8371-5463PhysicianMDJenniferGoldmanJennifer L. Goldman87Goldman, JenniferDirector, Drug Safety Service15917522Chavez-Bueno S, Bozdogan B, Katz K, Bowlware KL, Cushion N, Cavuoti D, Ahmad N, McCracken GH, Appelbaum PCAntimicrobial agents and chemotherapyChavez-Bueno S, Bozdogan B, Katz K, Bowlware KL, Cushion N, Cavuoti D, Ahmad N, McCracken GH, Appelbaum PC. Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas. Antimicrob Agents Chemother. 2005 Jun; 49(6):2283-8.Antimicrob Agents Chemother2005-06-01T00:00:002005Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas.28137820Smith MJ, Gonzalez D, Goldman JL, Yogev R, Sullivan JE, Reed MD, Anand R, Martz K, Berezny K, Benjamin DK, Smith PB, Cohen-Wolkowiez M, Watt KAntimicrobial agents and chemotherapySmith MJ, Gonzalez D, Goldman JL, Yogev R, Sullivan JE, Reed MD, Anand R, Martz K, Berezny K, Benjamin DK, Smith PB, Cohen-Wolkowiez M, Watt K. Pharmacokinetics of Clindamycin in Obese and Nonobese Children. Antimicrob Agents Chemother. 2017 04; 61(4).Antimicrob Agents Chemother2017-03-24T00:00:002017Pharmacokinetics of Clindamycin in Obese and Nonobese Children.PhD, BVSc, DABMM, FIDSA, FAAMRangarajSelvaranganRangaraj Selvarangan0.000000000000000.00000000000000126Selvarangan, Rangaraj0000-0003-3275-6657Director of Clinical Microbiology and Virology27164465Li A, Selvarangan R, Ogden R, French B, Yu DThe Pediatric infectious disease journalLi A, Selvarangan R, Ogden R, French B, Yu D. Clindamycin-susceptibility Rates of Methicillin-resistant Staphylococcus aureus Varies by Infection Type in Pediatric Patients. Pediatr Infect Dis J. 2016 08; 35(8):927-8.Pediatr Infect Dis J2016-08-01T00:00:002016Clindamycin-susceptibility Rates of Methicillin-resistant Staphylococcus aureus Varies by Infection Type in Pediatric Patients.PathologyPediatricsClinicalChildren's Mercy Kansas Citytrue1Director of Clinical Microbiology and VirologyDirector of Clinical Microbiology and Virologytrue1PhysicianPhysiciantrue1Director, Drug Safety ServiceDirector, Drug Safety Service0.2706370.1467263research area of0.6154260.2714113subject area for